Persistent Asset Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Persistent Asset Partners's NVO Position: Q2 2026 in Review
Persistent Asset Partners increased its Novo Nordisk (NVO) stake by 595% in Q2 2026, buying an estimated $942K and bringing the position to 25,600 shares worth $1.23M. The position accounts for 0.37% of the portfolio, ranked #55.
Persistent Asset Partners first reported a position in NVO in Q1 2025 and has held it in 4 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Persistent Asset Partners held 25,600 shares of Novo Nordisk worth $1.23M as of Q2 2026.
- Persistent Asset Partners bought 21,915 Novo Nordisk shares in Q2 2026, an estimated $942K.
- Novo Nordisk made up 0.37% of Persistent Asset Partners's portfolio in Q2 2026, its #55 holding.
- Persistent Asset Partners first reported a position in Novo Nordisk in Q1 2025 and has held it in 4 quarters since.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.